Key Insights

Highlights

Success Rate

100% trial completion (above average)

Research Leaders

6 sponsors active, led by International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT00266266CompletedPrimary

Human Papilloma Virus DNA Self-Test

NCT01206556CompletedPrimary

IMPAACT P1085: Human Papilloma Virus (HPV) Type-Specific Antibody

Showing all 2 trials

Research Network

Active Sponsors

  • International Maternal Pediatric Adolescent AIDS Clinical Trials Group1
  • National Institute of Allergy and Infectious Diseases (NIAID)1
  • University of Louisville1
  • James Graham Brown Cancer Center1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1

Top Investigators

Activity Timeline